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Giuseppe Destito, Gurer Budak, Ekmel Ozbay, Marianne Manchester,
Cengiz S. Ozkan,* and Mihrimah Ozkan*Extensively investigated and mutagenized Cow Pea Mosaic
Virus (CPMV) has been demonstrated in a variety of
nanoassemblies.[1–3] Iron Oxide (IO) has the potential to
surpass limits of detection in bioimaging applications.
Particularly g-Fe2O3 (maghemite) is considered as one of
the most desirable materials for technological and biomedical
applications due to its inherent biocompatible nature.[4,5]
Additionally, maghemite nanoparticles could be directed to an
organ, tissue, or tumor using an external magnetic field or
heated under an alternating magnetic field.[6,7] Based on the
unique magnetic properties of IO nanoparticles they have been
extensively used in biomedical applications, such as magnetic
resonance imaging, targeting drug delivery and hyperthermia
therapy detoxification and cell separation.[8–12][*] Prof. C. S. Ozkan, Y. Zhang
Department of Mechanical Engineering,
University of California Riverside
92521 Riverside, CA (USA)
E-mail: cozkan@engr.ucr.edu
Prof. M. Ozkan, A. A. Martinez-Morales
Department of Electrical Engineering,
University of California Riverside
92521 Riverside, CA (USA)
E-mail: mihri@ee.ucr.edu
Dr. N. G. Portney
Department of Bioengineering, University of California Riverside
92521 Riverside, CA (USA)
Dr. G. Destito, Prof. M. Manchester
Department of Cell Biology, The Scripps Research Institute
92037 La Jolla, CA (USA)
Prof. G. Budak





Department of Electrical and Electronics Engineering
and Department of Physics
Bilkent University
06800 Ankara (Turkey)
[**] This research was supported by the Center for Nanotechnology
for the Treatment, Understanding and Monitoring of Cancer
(NANOTUMOR) funded by the National Cancer Institute (NCI)
and by the FCRP Center on Functional Engineered Nano
Architectonics (FENA) funded by the Defense Advanced Research
Projects Agency (DARPA) and the Semiconductor Research
Corporation (SRC). The authors gratefully acknowledge Freida Dallal
for technical assistanceduringFTIR studiesandNissimAmos for fruitful
discussions on MFM imaging.
 2008 WILEY-VCH Verlag GmbCombining the two systems can be devised to enhance the
local magnetic field strength, by organizing monodisperse IO
clusters on a CPMV-T184C mutant viral template. It is known
that contrast enhancement is observed by use of super-
paramagnetic iron oxide nanoparticles (SPIONs) based MRI,
by creating large dipolar magnetic field gradients due to their
local field inhomogeneity. However, clustering a greater
number of IO nanoparticles can further improve contrast
beyond free particle SPIONs enhanced MRI, by creating a
cumulative dipole effect.[13]
CPMV-T184C is a useful model that has a well characterized
structure amenable to surface functionalization.[14] The
smallest repeating structure (asymmetric unit, composed of
a ‘‘small’’ (24kD) and ‘‘large’’ (42kD) subunit) displays 5
solvent exposed lysines used for IO linkage.[15] By insertion of
a cysteine, at residue 184 of the small subunit, anchorage of
CPMV to a self assembled monolayer (SAM) on gold substrate
pathway can be employed. A previously reported SAM on Au
stepwise assembly was used to integrate monodisperse
CPMV-IO hybrids for characterization.[16]
It is also been shown that aggregation of Iron oxide particles
can exhibit a greater magnetic dipole, and can be suited for
in bio-imaging, provided certain properties are met. Harris
et al.,[13] demonstrated protease activated aggregation of pegy-
lated iron oxide nanoparticles with enhanced MRI contrast to
be most beneficial in improving detection limits of small
tumors. Pegylation of CPMV was previously demonstrated to
improve circulation times and reduce immunogenicity.[2] Also,
based on enhanced permeability and retention effects (EPR),[17]
the longest retention times at tumor sites for nanoparticles
occurred for 60–400 nm.[18] Above 300 nm, there is vulnerability
to macrophage phagocytosis,[19] and below 10 nm, nanoparticles
can leave the systemic circulation via the lymph nodes.[20]
Therefore, the IONs-CPMV nanoparticle hybrid system synthe-
sized and MFM characterized in this report could be used for
contrast enhanced MRI applications.
In this work the local enhancement of field strength is
studied and demonstrated by magnetic force microscopy
(MFM) characterization of CPMV-IO hybrids bound to a
substrate by a stepwise assembly process (Fig. 1).
AFM was used to characterize structurally the as-synthesized
IO nanoparticles on a silicon substrate (Fig. 2A). In addition, a
histogram of the size distribution of the IO nanoparticles (Inset
Fig. 2A) determined from 68 individual measurements on












Figure 1. Stepwise substrate assembly of CPMV-IO hybrid.TEM was used to characterize the viral surface morpho-
logies before (inset Fig. 2B) and after (Fig. 2B) integration of
IO nanoparticles onto the viral capsid of monodisperse
CPMV-T184C mutants. In Figure 2B, the formation of
CPMV-IO hybrids can be observed. The structural integrity
and spatial organization of IO nanoparticles on the surface of
the virions demonstrate the decoration of IO nanoparticles on
CPMV-T184C virions.
Infrared spectroscopy by FTIR supports covalent attach-
ment of CPMV-IO hybrids. Additional amide II bond
character due to C–N stretches are dominant in the hybrid
(1652 cm1) and amide I (1648 cm1) by C––O stretches
(Fig. 3A). These vibrational modes are due to the resonating
peptide backbone of the CPMV-T184C capsid,[21] with amide
II (C–N) contributed by condensation of carboxylated IO and
CPMV-T184C lysines. CPMV-T184C reveals single amide I
stretch at 1647 cm1, a characteristic N-H stretch region
(3500–3000 cm1), and a small RNA peak at 1077 cm1
(Fig. 3B). Carboxylated IO shows carbonyl C––O stretch atFigure 2. Characterization of IO nanoparticles, CPMV-T184C, and
CPMV-IO hybrids. a) AFM topography of as synthesized single IO nano-
particles (white circles). Inset shows the histogram of the measured size
distribution for the single IO nanoparticles. b) TEM of CPMV-IO hybrids
recovered after thermal lift-off. Inset shows TEMof individual CPMV-T184C
virions.
Figure 3. FTIR spec
hybrids in PBS solu
boxylated Fe2O3 (ch
Adv. Mater. 2008, 20, 4816–4820  2008 WILEY-VCH Verlag GmbH & Co. KGaA1647 cm1 (Fig. 3C). Spectra were obtained
using 2 cm1 resolution within blank AgCl
windows as the background.
Atomic force microscopy in tapping mode
(AFM) and MFM were used to study the
topography and magnetic force gradient
(F0 ¼ @Fz/@z) along the z-axis, respectively.
The textured regions observed on each hybrid
(Fig. 4A, white selections) are indicative of IO
nanoclusters decorating the surface of single
virions. Because the two-dimensional array of
CPMV-IO hybrids was deposited onto the
substrate in a disordered manner, the topo-
graphy images show very large particles
(200 nm) in the background, consistent with
gold grains on the silicon substrate. As
discussed above, individual IO nanoparticles
were observed and measured to have a nominal
size of 11 nm (Fig. 2A). Therefore, in this
work it is presumed that each observed IOnanocluster is in fact composed of several single IO nanopar-
ticles. Due to the convolution of the tip with the closely packed
individual nanoparticles, these cannot be clearly differentiated
from each other but are rather imaged as a nanocluster.
Because in this work the substrate integration of a novel
nanoparticle hybrid assembly was developed, it was essential to
analyze the morphology to clearly show that two different
nanomaterials are integrated in each hybrid. Figure 4B provides
in greater detail the morphology of a single CPMV-IO hybrid.
The cross section (inset Fig. 4B) shows the particle features of
CPMV to be 60 nm, while the IO nanocluster is observed at
30 nm decorating the surface of the virion. To verify this
decoration as a uniquely different nanomaterial system
(e.g., IO), phase detection (Fig. 4C) was used. The difference
in probe/sample interaction between the organic (CPMV) and
inorganic (IO nanocluster) phase of the hybrid revealed that the
visco-elastic properties of the IO nanoclusters are essentially
different fromthose ofCPMV.The scanningprobeexperiencesa
repellent force by the inorganic phase compared to an attractive
force by the organic phase (inset Fig. 4C). Although the IO
nanocluster is perceived by the probe as a repulsive force in
the AFM phase detection, the magnetic force gradient imagetroscopy of CPMV-IO hybrids. a) Spectra of CPMV-IO
tion (pH¼ 7.5). b) Spectra of CPMV-T184C. c) Car-
eck) in PBS solution (pH¼ 7.5).












Figure 4. AFM and MFM imaging of single CPMV-IO hybrids. a) AFM
topography showing single hybrids (whites squares). AFM/MFM sche-
matic of dynamic lift-mode operation (inset). b) AFM topography, c) AFM
phase detection, d) MFM phase detection of two adjacent CPMV-IO
hybrids (white circle Fig. 3a) and their corresponding cross-sections
(insets).
4818(Fig. 4D) shows a very interesting result in which a ‘boundary-
effect’ can be observed. MFM measurements show that as the
magnetic probe scans the surface of a single hybrid, a repellent
force isfirst exertedon the magnetic probeat the perimeter of the
IO cluster. Then, as the probe moves away from the perimeter
and into the inside region of each IO nanocluster a strong
magnetic field gradient is measured by the probe and an
attractive force is experiencedbythe cantilever(inset Fig. 4D). A
similar ‘‘cluster edge effect’’ was observed by Pedreschi et al.,[22]
in the characterization and simulation of colloidal iron
nanoparticles. This boundary effect can be hypothesized to be
likely due to a symmetry-breaking effect at the perimeter of the
IO nanoclusters.
Furthermore, when MFM measurements were performedFigure 5. AFM and MFM imaging of CPMV-IO hybrids. a) AFM topography, b) AFM phase
detection and c) MFM phase detection showing hybrids with single IO nanoparticles (circles) and
IO nanoclusters (squares) on their surface. Inset in figures a)–c) show the cross-section of single
IO nanoparticle on the surface of a single virion (dark circle) as measured by AFM topography,
AFM phase detection and MFM phase detection, respectively.on hybrids with single IO nanoparticles on
their surface, the strong magnetic force
gradient measured on hybrids containing
nanoclusters could not be observed. Figure
5A shows a sample area exhibiting both
types of hybrids; hybrids with single IO
nanoparticles (circles) and hybrids contain-
ing IO nanoclusters (squares) on their sur-
face. The cross-section of a hybrid (enclosed
by a dark circle in Fig. 5A–C) with a single
IO nanoparticle shows the size of the
nanoparticle to be 12 nm (Inset Fig. 5A).
Meanwhile, no major difference can be
observed on the probe interaction with
hybrids containing single IO nanoparticleswww.advmat.de  2008 WILEY-VCH Verlag GmbH &during AFM/MFM phase detection measurements (Fig. 5B
and C, respectively). Cross-sections of a single hybrid during
AFM/MFM phase detection measurements (Inset Fig. 5B and
C, respectively) shows that in both cases the probe experiences
a slight repulsive force when scanning over the IO nanopar-
ticle. The measured force is comparable in both cases and
fundamentally of the same repulsive nature due to the
inorganic phase of the hybrid. In addition, Figure 5C shows
very clearly that only when the magnetic probe interacts with
the hybrids containing IO nanoclusters a strong magnetic field
gradient is measured during MFM. This data elucidates the
notion that the local magnetic field strength of this hybrid
system can be enhanced by covalently attaching (aggregating)
IO nanoparticles onto the surface of CPMV-T184C mutants.
During AFM/MFM characterization it was observed that
the ratio of hybrids with single IO nanoparticles to hybrids
containing IO nanoclusters was 1 to 5. Figure 6 shows the
histograms of the size distribution of IO nanoparticles
(Fig. 6A) and IO nanoclusters (Fig. 6B) for both types of
hybrids observed in this work. The measured size of single IO
nanoparticles measured by AFM on the CPMV-IO hybrids is
consistent with the size measured of the as synthesized IO
nanoparticles before covalent attachment. The results pre-
sented here demonstrate the feasibility of covalently attaching
IO nanoclusters on an organic scaffold (via substrate based
integration) as a mean to enhancing the local magnetic field
strength of IO nanoparticles.
To conclude, the enhanced local magnetic field strength was
qualitatively analyzed by MFM, demonstrating a characteristic
advantage for attaching derivatized magnetic IO nanoparticles
in an organic medium. During MFM characterization a
‘boundary-effect’ was observed at the CPMV/IO interface.
A strong magnetic field gradient was measured by the probe
and the cantilever experienced a strong attractive force during
MFM measurements. This strong interaction at a lift-off
distance of 65 nm was indicative of a strong local magnetic field
most likely due to a cumulative dipole effect of several IO
nanoparticles clustered together. Such assembly processes are
desirable in tailoring the physical-magnetic properties of a
mutant hybrid which could provide multifunctional nanopar-












Figure 6. Histogram of the measured size distributions of a) single IO
nanoparticles and b) IO nanoclusters covalently attached to the surface of
CPMV-T184C as measured by AFM characterization.Experimental
The chemicals, iron pentacarbonyl(80–90%, Aldrich), octyl ether
(99%, Aldrich), oleic acid (90%, Aldrich), 3-mercaptopropionic acid
(99þ %, Acros) and ethanol (200% proof) and all other chemicals used
for this study were of analytical grade and used with no further
purification. The synthesis of 11 nm size IO nanoparticles was carried
out under nitrogen atmosphere using standard schlenk technique. The
biocompatible g-Fe2O3–COOH nanoparticles were synthesized by
thermal decomposition of Fe(CO)5 and surface modified as described
in detail by Woo et al. [23]. IO nanoparticles protected by oleic acid
where synthesized in a 100 mL volume schlenk flask, where oleic acid
(1.92 mL, 6.08mmol) and octyl ether (20 mL) were taken and heated up
to 100 8C and iron pentacarbonyl (0.40mmol, 3.04mmol) was added and
continued to reflux for 2 h. The reaction mixture was aerated for 14 h at
80 8C and refluxed for another 2 h. In order to obtain the Fe rich
surface, nitrogen gas was bubbled into the reaction mixture for 2 h and
iron pentacarbonyl (0.04 mL, 0.30mmol) was added at 100 8C and
continued to reflux for 1 h. The above reaction mixture was cooled
down to ambient temperature. 3-Mercaptopropionic acid (0.053 mL,
0.61mmol) was added to the above mixture and refluxed for 1 h. After
cooling down to ambient temperature, excess ethanol was added to
isolate IONPs-MPA by magnetic decantation. The mixture of
chloroform/methanol/water was added to eliminate the excess
surfactant. Pure product of IO nanoparticles tangled with
3-mercaptopropionic acid was isolated using a magnet.
CPMV-T184C was generated by site directed mutagenesis as
described by Portney et al. [24]. The chimeric CPMVs were purified
from the infected leaves by standard methods described by Dalsgaard
et al., with some modifications [25]. Frozen leaves were homogenized
in a Waring blender using 0.1 M potassium phosphate pH 7.0, 0.5%
b-mercaptoethanol. After low-speed centrifugation, chloroform-
butanol 1:1 was added to the supernatant and stirred for 20 min at
4 8C. The aqueous phase was separated by centrifugation and the virus
was precipitated using 8% (w/v) polyethylene glycol 8000 and 0.2 M
NaCl, stirring for 30 min at 4 8C. After centrifugation the virus pellet
was resuspended in 0.1 M potassium phosphate pH 7.0 and 0.2 M DTT,
and was layered on top of a 30% sucrose solution for ultracentrifuga-
tion (42,000 rpm, 3 h at 4 8C). The pellet was re-suspended in 3–5 mL of
0.1 M phosphate buffer at pH 7.0 containing 0.1 M DTT. The CPMVAdv. Mater. 2008, 20, 4816–4820  2008 WILEY-VCH Verlparticles were further purified on 10–40% sucrose gradients
(28,000 rpm for 3 h at 4 8C). Finally the virus was concentrated and
any residual DTT was removed by ultrapelleting the virus through a
30% sucrose cushion (42,000 rpm for 3 h at 4 8C). CPMV-T184C
contains 60 copies each of L and S proteins, with external lysines found
at positions 38 and 82 on the small subunit and 34, 99, and 199 on the
large subunit, for a total of 300 external lysines per capsid. Cysteines
are inserted at position 184 of small subunit, achieving 60 total terminal
cysteines per virus.
Deposition of maleimide disulfide/hydroxyl-capped disulfide alka-
nethiol (MED/EG3-EG3) species was performed by addition of
ethanol washed and N2 gassed Au substrate (Platypus Technologies)
into 1 mM MED/EG3-EG3 solution (2 mL) containing 1.1 mM total
disulfide for up to 18 h, followed by another ethanol wash and N2
drying. MED/EG3-EG3 coated Au substrates were submerged in a
CPMV-T184C stock (5 mg mL1) containing 2 mM tris(carboxy-
ethyl)phosphine hydrochloride (TCEP) reducing agent for 1.5 h at
RT. Following incubation, removed substrates were successively rinsed
in PBS, Tween-20 (1 wt %), and DI water, followed by N2 gas drying
and storage in vacuum. Short reaction times in the presence of TCEP
are used to prevent aggregation and saturation of CPMV on substrate,
and avoid nonspecific adsorption effects to achieve a homogeneous
sample.
Carbodiimide chemistry was used to condense solvent exposed
primary amine lysine residues on CPMV-T184C with carboxylated IO
[26]. To a solution of IO in PBS buffer (pH¼ 7.5), 50 mM EDC
(1-ethyl3-(3-dimethylaminopropyl)carbodiimide hydrochloride) was
added to form a highly reactive O-acylisourea intermediate for 15 min,
followed by 15 min ester formation with 5 mM sulfo-NHS
(N-hydroxysulfosuccinimide) to extend the half life of the carboxylate
to hours [27]. Following carboxylate activation, CPMV-T184C coated
Au substrate was submersed for 4 h with gentle stirring. Following
reaction, substrate was washed with PBS, Tween, and two DI washes
before N2 drying and storage in vacuum.
CPMV-IO nanoparticles hybrids on Au substrate were desorbed by
thermal lift off at 50 8C for 30 min in 500 uL DI water. Lift off sample
(0.044 mg mL1) was added to plasma oxidized grid using Harrick
PDC-326 plasma cleaner. TEM analysis was performed on 400 mesh
plain carbon support film on Cu TEM grid (EMS, cat#CF400-Cu) at
100 kV accelerating voltage (FEI-Philips CM300). FTIR spectra were
obtained by wetting an AgCl window with each sample into instrument
(Bruker Equinox 55 FTIR spectrometer). OPUS spectroscopy soft-
ware was used with 1 cm1 resolution, where a PBS background
averaged 20 scans. A/MFM experiments were performed with a
Multimode V SPM system (Veeco Instruments Inc.). During
experimental measurements a magnetic probe (MESP Co/Cr silicon
coated tip, ROC 25 nm) with a resonant frequency 60–100 kHz was
used. The nominal spring constant of the cantilever is 2.8 N m1 with
coercivity400 Oe. MFM measurements were performed in a dynamic
lift-mode operation (inset Fig. 3A) at a lift-off distance of 65 nm over
the sample, which was optimized in order to reduce the topographical
interference and prevent false imaging (i.e., non-magnetic) of the
CPMV-IO hybrids. All measurements were taken under open
environment and ambient conditions.
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